Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(1S,2S,3R,6S)-6-[[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]amino]-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol | valienamine-derived N1->3-linked pseudosaccharide | Rattus norvegicus | |
(1S,2S,3R,6S)-6-[[(2R,3S,4S,5S,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]amino]-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol | valienamine-derived N1->3-linked pseudosaccharide | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Glc2Man9GlcNAc2 + H2O | - |
Rattus norvegicus | GlcMan9GlcNAc2 + beta-D-glucopyranose | - |
? | |
GlcMan9GlcNAc2 + H2O | - |
Rattus norvegicus | Man9GlcNAc2 + beta-D-glucopyranose | - |
? |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.072 | - |
cleavage-1, pH not specified in the publication, temperature not specified in the publication | Rattus norvegicus | (1S,2S,3R,6S)-6-[[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]amino]-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol | |
0.143 | - |
cleavage-2, pH not specified in the publication, temperature not specified in the publication | Rattus norvegicus | (1S,2S,3R,6S)-6-[[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]amino]-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol | |
0.236 | - |
cleavage-2, pH not specified in the publication, temperature not specified in the publication | Rattus norvegicus | (1S,2S,3R,6S)-6-[[(2R,3S,4S,5S,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]amino]-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol |